[go: up one dir, main page]

WO2012166705A3 - Nanofibres et hydrogels supramoléculaires à base de conjugués acide aminé-nucléobase-glucoside - Google Patents

Nanofibres et hydrogels supramoléculaires à base de conjugués acide aminé-nucléobase-glucoside Download PDF

Info

Publication number
WO2012166705A3
WO2012166705A3 PCT/US2012/039821 US2012039821W WO2012166705A3 WO 2012166705 A3 WO2012166705 A3 WO 2012166705A3 US 2012039821 W US2012039821 W US 2012039821W WO 2012166705 A3 WO2012166705 A3 WO 2012166705A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleobase
amino acid
supramolecular
hydrogels based
glycoside conjugates
Prior art date
Application number
PCT/US2012/039821
Other languages
English (en)
Other versions
WO2012166705A2 (fr
Inventor
Bing Xu
Original Assignee
Brandeis University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brandeis University filed Critical Brandeis University
Publication of WO2012166705A2 publication Critical patent/WO2012166705A2/fr
Publication of WO2012166705A3 publication Critical patent/WO2012166705A3/fr
Priority to US14/093,974 priority Critical patent/US10093674B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L31/125—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L31/129—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix containing macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Materials Engineering (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Composite Materials (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne des promoteurs d'hydrogel qui comportent une nucléobase, un acide aminé et un glucoside. Ces promoteurs d'hydrogel présentent une résistance accrue aux protéases et peuvent former par auto-assemblage des nanofibres ou des hydrogels supramoléculaires. Ces structures supramoléculaires peuvent être utilisées pour favoriser la croissance de cellules ou pour délivrer une substance à une cellule.
PCT/US2012/039821 2011-05-31 2012-05-29 Nanofibres et hydrogels supramoléculaires à base de conjugués acide aminé-nucléobase-glucoside WO2012166705A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/093,974 US10093674B2 (en) 2011-05-31 2013-12-02 Supramolecular nanofibers and hydrogels based on nucleic acids functionalized with nucleobases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161491544P 2011-05-31 2011-05-31
US61/491,544 2011-05-31

Related Child Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/039822 Continuation-In-Part WO2012166706A2 (fr) 2011-05-31 2012-05-29 Nanofibres et hydrogels supramoléculaires à base d'oligopeptides fonctionnalisés par des nucléobases

Publications (2)

Publication Number Publication Date
WO2012166705A2 WO2012166705A2 (fr) 2012-12-06
WO2012166705A3 true WO2012166705A3 (fr) 2013-02-28

Family

ID=47260243

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/039821 WO2012166705A2 (fr) 2011-05-31 2012-05-29 Nanofibres et hydrogels supramoléculaires à base de conjugués acide aminé-nucléobase-glucoside

Country Status (1)

Country Link
WO (1) WO2012166705A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014138367A1 (fr) * 2013-03-06 2014-09-12 Brandeis University Inhibition de la croissance tumorale avec des agrégats de petites molécules
US10232037B2 (en) 2014-02-03 2019-03-19 Brandeis University Supramolecular hydrogel of fMLF-based molecules and use thereof
US10857243B2 (en) 2014-04-09 2020-12-08 Brandeis University Enzymatically responsive magnetic particles and their use
EP3310396A4 (fr) 2015-06-16 2019-02-27 The Johns Hopkins University Hydrogels thérapeutiques à base de nanofibres pour le traitement local des maladies liées au cerveau
US12246068B2 (en) 2017-01-06 2025-03-11 Brandeis University Enzymatically activatable peptide-redox modulator conjugates and use thereof
US11839661B2 (en) 2017-08-15 2023-12-12 Brandeis University Rapid formation of supramolecular hydrogels by short peptide and bioactive small molecules
US11834517B2 (en) 2017-09-18 2023-12-05 Brandeis University Branched peptides for enzymatic assembly and mitochondria drug delivery
WO2019055988A1 (fr) 2017-09-18 2019-03-21 Brandeis University Peptides ramifiés pour assemblage enzymatique et administration de médicament à des mitochondries

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278284A (en) * 1992-05-14 1994-01-11 Miller Brewing Company Protein purification method
US20020081726A1 (en) * 2000-09-25 2002-06-27 Brenda Russell Microfabrication of membranes for the growth of cells
US20080057005A1 (en) * 2005-03-24 2008-03-06 Jean-Marie Lehn Hydrogels for the controlled release of bioactive materials

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278284A (en) * 1992-05-14 1994-01-11 Miller Brewing Company Protein purification method
US20020081726A1 (en) * 2000-09-25 2002-06-27 Brenda Russell Microfabrication of membranes for the growth of cells
US20080057005A1 (en) * 2005-03-24 2008-03-06 Jean-Marie Lehn Hydrogels for the controlled release of bioactive materials

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
LI, X. ET AL.: "Multifunctional, Biocompatible Supramolecular Hydrogelators Consist Only for Nucleobase, Amino Acid, and Glycoside", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 133, 19 September 2011 (2011-09-19), pages 17513 - 17518 *
YANG, Z. ET AL.: "Supramolecular hydrogels based on biofunctional nanofibers of self-assembled small molecules", JOURNAL OF MATERIALS CHEMISTRY, vol. 17, 2007, pages 2385 - 2393 *

Also Published As

Publication number Publication date
WO2012166705A2 (fr) 2012-12-06

Similar Documents

Publication Publication Date Title
WO2012166705A3 (fr) Nanofibres et hydrogels supramoléculaires à base de conjugués acide aminé-nucléobase-glucoside
WO2012061719A3 (fr) Dispositifs d'origami d'adn
EP2325896A4 (fr) Electrode frontale pour pile solaire permettant de réduire la perte de puissance, et pile solaire comprenant cette électrode
WO2008122027A3 (fr) Nouvelle electrode
WO2010030598A3 (fr) Formulations pharmaceutiques comprenant du pemetrexed
WO2010102116A3 (fr) Pile solaire ayant plusieurs donneurs d'électrons
EP2315810B8 (fr) Polyuréthanes antistatiques ou électroconducteurs et procédé de production
WO2012056457A3 (fr) COMPOSITIONS ET PROCÉDÉS D'ACTIVATION D'EXPRESSION PAR UN ARNmi ENDOGÈNE SPÉCIFIQUE
EP3049116A4 (fr) Administration de gènes médiée par des nanoparticules, édition génomique et modification ciblée par un ligand dans diverses populations de cellules
HK1200706A1 (en) Aqueous oral care compositions
WO2011160021A3 (fr) Dérivés de fullerènes
WO2010129288A3 (fr) Marqueurs d'évènement comestibles à haute fiabilité et leurs procédés d'utilisation
EP2605314A4 (fr) Ensemble d'électrodes ayant des structures en forme de fibres, et batterie le comprenant
WO2011085004A3 (fr) Cellule photovoltaïque comprenant un polymère contenant du benzodithiophène
WO2011133902A3 (fr) Milieu de culture cellulaire comprenant des petits peptides
WO2015047484A3 (fr) Systèmes électrochimiques et procédés pour récupérer de l'énergie thermique
EP2319109A4 (fr) Plaque électrode de batterie, procédé de fabrication associé et batterie comportant ladite plaque électrode
WO2012031164A3 (fr) Administration de médicaments par réseaux de nanotubes de carbone
WO2012116073A3 (fr) Dendron-hélices amphiphiles, micelles de ceux-ci et utilisations
WO2009102569A3 (fr) Nouvelles lignées cellulaires et méthodes associées
WO2010111659A8 (fr) Cellules initiatrices de tumeur et procédés pour les utiliser
FR2957360B1 (fr) Electrolyseur a haute temperature (eht) comprenant une pluralite de cellules, a fonctionnement ameliore en cas de casse d'au moins une cellule et en veillissement
WO2007008861A3 (fr) Procedes de transfert d'energie par cellules photovoltaiques
EP2327119A4 (fr) Accumulateur bipolaire, procédé de fabrication de l accumulateur bipolaire, électrode bipolaire, procédé de fabrication de l électrode bipolaire et batterie assemblée
WO2012068441A3 (fr) Sels d'intedanib et leurs formes à l'état solide

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12792966

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12792966

Country of ref document: EP

Kind code of ref document: A2